skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Discovery and Preclinical Characterization of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic Acid (PF-06409577), a Direct Activator of Adenosine Monophosphate-activated Protein Kinase (AMPK), for the Potential Treatment of Diabetic Nephropathy

Journal Article · · Journal of Medicinal Chemistry

Adenosine monophosphate-activated protein kinase (AMPK) is a protein kinase involved in maintaining energy homeostasis within cells. On the basis of human genetic association data, AMPK activators were pursued for the treatment of diabetic nephropathy. Identification of an indazole amide high throughput screening (HTS) hit followed by truncation to its minimal pharmacophore provided an indazole acid lead compound. Optimization of the core and aryl appendage improved oral absorption and culminated in the identification of indole acid, PF-06409577 (7). Compound 7 was advanced to first-in-human trials for the treatment of diabetic nephropathy.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States)
Sponsoring Organization:
INDUSTRY; USDOE Office of Science (SC), Basic Energy Sciences (BES)
Grant/Contract Number:
AC02-06CH11357
OSTI ID:
1368232
Journal Information:
Journal of Medicinal Chemistry, Vol. 59, Issue 17; ISSN 0022-2623
Publisher:
American Chemical Society (ACS)Copyright Statement
Country of Publication:
United States
Language:
ENGLISH
Citation Metrics:
Cited by: 88 works
Citation information provided by
Web of Science

References (32)

Diabetic nephropathy: where are we on the journey from pathophysiology to treatment? journal February 2016
Diabetic Nephropathy: Focus on Current and Future Therapeutic Strategies journal March 2016
New loci associated with kidney function and chronic kidney disease journal April 2010
Chronic Kidney Disease: Novel Insights from Genome-Wide Association Studies journal January 2011
Dissecting the Role of 5′-AMP for Allosteric Stimulation, Activation, and Deactivation of AMP-activated Protein Kinase journal October 2006
The AMPK signalling pathway coordinates cell growth, autophagy and metabolism journal September 2011
AMP-activated protein kinase: a cellular energy sensor that comes in 12 flavours journal March 2016
AMPK in Health and Disease journal July 2009
The Genotype-Tissue Expression (GTEx) project journal May 2013
AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function journal October 2013
AMP-activated Protein Kinase (AMPK) Negatively Regulates Nox4-dependent Activation of p53 and Epithelial Cell Apoptosis in Diabetes journal November 2010
A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy journal February 2007
AMPK Mediates the Initiation of Kidney Disease Induced by a High-Fat Diet journal September 2011
Regulation of lipid accumulation by AMK-activated kinase in high fat diet–induced kidney injury journal March 2014
Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state journal July 2010
5-Aminoimidazole-4-carboxamide-1-β-d-ribofuranoside (AICAR) Effect on Glucose Production, but Not Energy Metabolism, Is Independent of Hepatic AMPK in Vivo journal February 2014
Beyond AICA riboside: In search of new specific AMP-activated protein kinase activators journal January 2009
Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome journal June 2006
Structural basis of AMPK regulation by small molecule activators journal December 2013
Structural Basis for AMPK Activation: Natural and Synthetic Ligands Regulate Kinase Activity from Opposite Poles by Different Molecular Mechanisms journal August 2014
Direct AMP-activated protein kinase activators: a review of evidence from the patent literature journal November 2012
AMPK activators: mechanisms of action and physiological activities journal April 2016
Mechanism of Action of A-769662, a Valuable Tool for Activation of AMP-activated Protein Kinase journal September 2007
Development of a new permeability assay using low‐efflux MDCKII cells journal November 2011
An improved method for the determination of distribution coefficients journal February 1990
Comparison of metabolite profiles generated in Aroclor-induced rat liver and human liver subcellular fractions: Considerations for in vitro genotoxicity hazard assessment journal October 2008
Probing the enzyme kinetics, allosteric modulation and activation of α1- and α2-subunit-containing AMP-activated protein kinase (AMPK) heterotrimeric complexes by pharmacological and physiological activators journal February 2016
A Novel Relay Method for Determining Low-Clearance Values journal May 2012
Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding journal May 2003
Choreography of AMPK activation journal December 2014
Diabetic nephropathy and long-term treatment effects of rosiglitazone and enalapril in obese ZSF1 rats journal June 2011
Baculovirus expression, purification, and characterization of human protein phosphatase 2A catalytic subunits α and β journal January 2006

Cited By (18)

Purinergic Signalling: Therapeutic Developments journal September 2017
Synthesis and structure–activity relationships of pyrazolo‐[3,4‐ b ]pyridine derivatives as adenosine 5'‐monophosphate‐activated protein kinase activators journal July 2019
The autophagy initiator ULK1 sensitizes AMPK to allosteric drugs journal September 2017
Prediction of Optimal Drug Schedules for Controlling Autophagy journal February 2019
Miniaturized and Automated Synthesis of Biomolecules—Overview and Perspectives journal April 2019
Targeting AMPK in Diabetes and Diabetic Complications: Energy Homeostasis, Autophagy and Mitochondrial Health journal October 2019
Neural-Symbolic Machine Learning for Retrosynthesis and Reaction Prediction journal February 2017
Targeting of lipid metabolism with a metabolic inhibitor cocktail eradicates peritoneal metastases in ovarian cancer cells journal July 2019
A Novel Phenylchromane Derivative Increases the Rate of Glucose Uptake in L6 Myotubes and Augments Insulin Secretion from Pancreatic Beta-Cells by Activating AMPK journal October 2017
Identification of a novel 2-oxindole fluorinated derivative as in vivo antitumor agent for prostate cancer acting via AMPK activation journal March 2018
All-Trans-Retinoic Acid Suppresses Neointimal Hyperplasia and Inhibits Vascular Smooth Muscle Cell Proliferation and Migration via Activation of AMPK Signaling Pathway journal May 2019
6-Chloro-5-[4-(1-Hydroxycyclobutyl)Phenyl]-1 H -Indole-3-Carboxylic Acid is a Highly Selective Substrate for Glucuronidation by UGT1A1, Relative to β -Estradiol journal September 2018
Immunologic and endocrine functions of adipose tissue: implications for kidney disease journal December 2017
Selective Activation of AMPK β 1-Containing Isoforms Improves Kidney Function in a Rat Model of Diabetic Nephropathy journal March 2017
Direct Activation of Adenosine Monophosphate-Activated Protein Kinase (AMPK) by PF-06409577 Inhibits Flavivirus Infection through Modification of Host Cell Lipid Metabolism journal July 2018
Prediction of Optimal Drug Schedules for Controlling Autophagy preprint January 2018
2-[2-(4-(trifluoromethyl)phenylamino)thiazol-4-yl]acetic acid (Activator-3) is a potent activator of AMPK journal June 2018
Identification of Direct Activator of Adenosine Monophosphate-Activated Protein Kinase (AMPK) by Structure-Based Virtual Screening and Molecular Docking Approach journal June 2017